Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog

References

• BARRY, M. and FEELY, J., 1990, Enzyme induction and inhibition. Pharmacology and Therapeutics, 48, 71–94.
   PubMed Web of Science ®Google Scholar
• BERMUDEZ, L. E., KOLONOSKI, P., YOUNG, L. S. and INDERLIED, C. B., 1994, Activity of KRM-1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. Antimicrobial Agents and Chemotherapy, 38, 1844–1848.
   Web of Science ®Google Scholar
• DURAND, D. V., HAMPDEN, C., BOOBIS, A. R., PARK, B. K. and DABIES, D. S., 1986, Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative. British Journal of Clinical Pharmacology, 21, 1–7.
   PubMed Web of Science ®Google Scholar
• EGUCHI, K., NISHIBE Y., BABA, T. and OHNO, K., 1996, Quantitation of cytochrome P450 enzymes (CYP1A1/2,2B11,2C11 and 3Al2) in dog liver microsomes by enzyme-linked immunosorbent assay. Xenobiotica, 26, 755–764 .
   Google Scholar
• EMORI, M., SAITO, H., SATO, K., TOMIOKA, H., SETouAwA, T. and HIDAKA, T., 1993, Therapeutic efficacy of benzoxazinorifamycin KRM -1648 against experimental Mycobacterium avium infection induced in rabbits. Antimicrobial Agents and Chemotherapy, 37, 722–728.
   PubMed Web of Science ®Google Scholar
• GIBSON, G. G. and SKETT, P., 1994, In vitro assays for drug-metabolizing enzymes. In Introduction to Drug Metabolism, 2nd edn (Glasgow: Blackie Academic & Professional), pp. 217–240.
   Google Scholar
• GRANGE, J. M., WINSTANLEY, P. A. and DAVIES, P. D. O., 1994, Clinically significant drug interactions with antituberculosis agents. Drug Safety, 11, 242–251.
   PubMed Web of Science ®Google Scholar
• HOSOE, K., MAE, T., KONISHI, E., FUJII, K., YAMASHITA, K., YAMANE, T., HIDAKA, T. and OHASHI, T., 1996, Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs. Anti-microbial Agents and Chemotherapy, 40, 2749–2755.
   PubMed Web of Science ®Google Scholar
• Imm, Y., IT°, A. and SATO, R., 1966, Evidence for biochemically different types of vehicles in the hepatic microsomal fraction. Journal of Biochemistry, 60, 417–428.
   Google Scholar
• INDERLIED, C. B., BARBARA-BURNHAM L., Wu, M., YOUNG, L. and BERMUDEZ, L. E., 1994, Activity of the benzoxazinorifamycin KRM-1648 against the Mycobacterium avium complex in vitro and in macrophages. Antimicrobial Agents and Chemotherapy, 38, 1838–1843.
   Google Scholar
• KLEMENS, S. P., GROSSI, M. A. and CYNAMON, M. H., 1994, Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy, 38, 2245–2248.
   PubMed Web of Science ®Google Scholar
• KUZE, F., YAMAMOTO, T., AMITANI, R. and Suzum, K., 1991, In vitro activities of new rifamycin derivatives against mycobacteria. Kekkaku, 66, 7–12.
   PubMedGoogle Scholar
• Liu, D. Y. and WANG, Y. S., 1990, Inductive effects of rifapentine on mice hepatic mixed function oxidase system. Methods and Findings in Experimental and Clinical Pharmacology, 12, 109–113.
   PubMedGoogle Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• LUNA-HERRERA, J ., REDDY, M. V. and GANGADHARAM, P. R. J., 1995, In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli. Antimicrobial Agents and Chemotherapy, 39, 440–444.
   Google Scholar
• MAE, T., HOSOE, K., FUJII, K., YAMASHITA, K., YAMANE, T., HIDAKA, T. and OHASHI, T., 1996, In vitro metabolism of a rifamycin derivative by animal and human liver microsomes, whole blood and expressed human CYP3A isoforrn. Xeitobiotka, 26, 793–802.
   PubMed Web of Science ®Google Scholar
• MATSUBARA, T., Korsu, M., Touum, A., TOCHINO, Y. and S UGENO, K., 1976, Quantitative determination of cytochrome P-450 in rat liver homogenate. Analytical Biochemistry, 75, 596–603.
   PubMed Web of Science ®Google Scholar
• NASH, T., 1953, The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemistry, 55, 416–421.
   Web of Science ®Google Scholar
• OESCH, F., ARAND, M., STROLIN BENEDETTI, CASTELLE, M.G. and DOSTERT, P., 1996, Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver. Journal of Antimicrobial Chemo-therapy, 37, 1111–1119.
   Google Scholar
• OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2379–2385.
   PubMed Web of Science ®Google Scholar
• PERUCCA, E., GRIMALDI, R., FRIGO, G. M., SAADI, A., MOING, H. and OHNHAUS, E. E., 1988, Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects. European Journal of Clinical Pharmacology, 34, 595–599.
   PubMed Web of Science ®Google Scholar
• SAITO, H., TOMIOKA, H., SATO, K., EMORI, M., YAMANE, T., YAMASHITA, K., HOSOE, K. and HIDAKA, T., 1991, In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins. Antimicrobial Agents and Chemotherapy, 35, 542–547.
   PubMed Web of Science ®Google Scholar
• SUET, M. S., FAULKNER, K. M., HOLMANS, P. L., FISHER, C. W. and ESTABROOK, R. W., 1995, The effects of cytochrome b5, NADPH-P450 reductase and lipid on the rate of 6)3-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein. Archives of Biochemistry and Biophysics, 318, 314–321.
   PubMed Web of Science ®Google Scholar
• SKINNER, M. H. and BLASCHKE, T. E., 1995, Clinical pharmacokinetics of rifabutin. Clinical Pharmaco-kinetks, 28, 115–125.
   PubMed Web of Science ®Google Scholar
• STROLIN BENEDETTI, M. and DOSTERT, P., 1994, Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies. Environmental Health Perspectives, 102\(suppl. 9), 101–105.
   PubMed Web of Science ®Google Scholar
• STROLIN BENEDETTI, M., EFTHYMIOPOULOS, C., SASSELLA, D., MORO, E. and REPETTO, M., 1990, Autoinduction of rifabutin metabolism in man. Xenobiotka, 20, 1113–1119.
   PubMed Web of Science ®Google Scholar
• TOMIOKA, H., SAITO, H., FUJII, K., SATO, K and HIDAKA, T., 1993, In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex determined by the radiometric method. Antimicrobial Agents and Chemotherapy, 37, 67–70.
   Google Scholar
• TOMIOKA, H., SAITO, H., SATO, K., YAMANE, T., YAMASHITA, K., HOSOE, K., FILM, K. and HIDAKA, T., 1992, Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrobial Agents and Chemotherapy, 36, 387–393.
   PubMed Web of Science ®Google Scholar
• VENKATESAN, K., 1992, Pharmacokinetic drug interactions with rifampicin. Clinical Phannacokinetks, 22, 47–65.
   PubMed Web of Science ®Google Scholar
• WALLACE, R. J. JR, BROWN, B. A., GRIFFITH, D. E., GIRARD, W. and TANAKA, K., 1995, Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium—M. intracellulare infection. Journal of Infectious Diseases, 171, 747–750.
   Google Scholar
• WASKELL, L. A., VIGNE, J. L. and VERGERES, G., 1991, Site of action of substrates requiring cytochrome b5 for oxidation by cytochrome P450. Methods in Enzymology, 206, 523–529.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO, T., AMITANI, R., KUZE, F. and Suzum, K., 1990, In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex. Kekkaku, 65, 805–810.
   PubMedGoogle Scholar
• YAMANE, T., HASHIZUME, T., YAMASHITA, K., KONISHI, E., HOSOE, K., HIDAKA, T., WATANABE, K., KAWAHARADA, H., YAMAMOTO, T. and KUZE, F., 1993, Synthesis and biological activity of 3"-hydroxy-5.-aminobenzoxaziorifamycin derivatives. Chemical and Pharmaceutical Bulletin, 41, 148–155.
   PubMed Web of Science ®Google Scholar
• ZHANG, X. J. and THOMAS, P. E., 1996, Erythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats. Drug Metabolism and Disposition, 24, 23–27.
   PubMed Web of Science ®Google Scholar